1014
Z. Liu, A. Nefzi / Tetrahedron Letters 53 (2012) 1013–1014
O
H
O
b, c, d
N
Fmoc
NH2
S
a
N
H
NH2
N
H
OH
S
O
1
Tr t
2
O
O
R1
X
O
R1
X
O
N
H
O
N
H
O
n
N
n
N
e
f
N
H
H2N
S
S
3
4
Scheme 1. Reagents and conditions: (a) L-Fmoc-Cys(Trt)-OH, DIC, HOBt, DMF, 2 h; (b) TFA/TIS/DCM (5:5:90), 30 min; (c) 2-bromoacetic acid, DIEA, DMF, overnight; (d) 20%
piperidine/DMF, (2 Â 10 min); (e) isocyanides, ketones, acetonitrile/methanol (4:1), 65 °C, 24 h8; (f) HF cleavage, 0 °C, 1.5 h.
Table 1
3. (a) Dömling, A. Chem. Rev. 2006, 106, 17–89; (b) Marcaccini, S.; Torroba, T. Nat.
Protoc. 2007, 2, 632–639; (c) Dömling, A.; Ugi, I. Angew. Chem., Int. Ed. 2000, 39,
3168–3210; (d) Ugi, I.; Werner, B.; Dömling, A. Molecules 2003, 8, 53–56; (e)
Main, M.; Snaith, J. S.; Meloni, M. M.; Jauregui, M.; Sykes, D.; Faulkner, S.;
Kenwright, A. M. Chem. Commun. 2008, 5212–5214.
4. (a) Pulici, M.; Quartieri, F.; Felder, E. R. J. Comb. Chem. 2005, 7, 463–473; (b)
Hoel, A. M. L.; Nielson, J. Tetrahedron Lett. 1999, 40, 3941–3944.
5. Gray, D. L.; Xu, W.; Campbell, B. M.; Dounay, A. B.; Barta, N.; Boroski, S.; Denny,
L.; Evans, L.; Stratman, N.; Probert, A. Bioorg. Med. Chem. Lett. 2009, 19, 6640–
6670.
6. Carr, G.; Williams, D. E.; Diaz-Marrero, A. R.; Patrick, B. O.; Bottriell, H.; Balgi, A.
D.; Donohue, E.; Roberge, M.; Andersen, R. J. J. Nat. Prod. 2010, 73, 422–427.
7. Nefzi, A.; Dooley, C.; Ostresh, J. M.; Houghten, R. A. Bioorg. Med. Chem. Lett.
1998, 8, 2273–2278.
8. Liu, Z.; Nefzi, A. J. Comb. Chem. 2010, 12, 566–570.
9. General procedure for the synthesis of N-substituted thiomopholinone
R1
O
NH
( )n
X
H2N
O
N
O
S
Entry
R1
X
n
Obtained MW
Yielda (%)
Purityb (%)
4a
4b
4c
4d
4e
4f
4g
4h
4i
Benzyl
Benzyl
Benzyl
Benzyl
C
C
C
O
C
C
C
O
C
C
C
O
1
2
3
2
1
2
3
2
1
2
3
2
362.5 (MH+)
376.5 MH+)
390.5 (MH+)
378.5 (MH+)
354.5 (MH+)
368.5 (MH+)
382.5 (MH+)
370.5 (MH+)
328.4 (MH+)
342.5 (MH+)
356.5 (MH+)
344.4 (MH+)
78
81
72
73
75
79
75
67
71
76
73
62
82
85
86
85
91
82
86
90
89
81
83
93
derivatives:
A 100 mg sample of p-methylbenzhydrylamine (MBHA) resin
(1.1 mequiv/g, 100–200 mesh) was contained within a sealed polypropylene
mesh packet. Reactions were carried out in polyethylene bottles. Following
neutralization with 5% diisopropylethylamine (DIEA) in dichloromethane
Cyclohexyl
Cyclohexyl
Cyclohexyl
Cyclohexyl
nButyl
(DCM),
L-Fmoc-Cys(Trt)-OH (6 equiv) was coupled in the presence of
hydroxybenzotriazole (HOBt, 6 equiv) and diisopropylcarbodiimide (DIC,
6 equiv.) in anhydrous DMF for 2 h. Following removal of the Trt group with
TFA/TIS/DCM (5:5:90) and washing with DCM (3Â), the resin was allowed to
react overnight with 2-bromoacetic acid (10 equiv) and DIEA (5 equiv) in DMF,
and then the Fmoc group was deprotected with 20% piperidine in DMF
(2 Â 10 min). The generated resin 2 was put in a solution of a ketone (2 equiv)
in acetonitrile/methanol (4:1) for 1 h at 65 °C, and then an isocyanide (2 equiv)
was added. After allowing the mixture to react at 65 °C for 24 h, the resin was
washed with MeOH (3Â), DMF (3Â), DCM (3Â) and dried. The crude product
was released from the resin by HF cleavage at 0 °C for 1.5 h and then purified by
preparative HPLC10 and characterized by LC–MS under ESI positive mode. 1H
NMR and 13C NMR. ESI-MS (m/z) of 4b: 376.5 (M+H); 1H NMR (500 MHz, DMSO
d6): d 1.23–1.69 (m, 6H); 1.84–2.21 (m, 4H); 3.10–3.52 (m, 4H); 4.24 (m, 2H);
4.91 (m, 1H); 7.19–7.24 (m, 5H); 7.62 (s, 1H); 8.58 (s, 1H); 8.88 (t, 1H, J = 5.75).
13C NMR (125 MHz, DMSO d6): d 21.89, 22.17, 24.78, 28.20, 29.31, 30.00, 32.73,
42.33, 56.30, 65.63, 126.43, 126.89, 128.04, 139.62, 167.65, 173.33, 174.52.
4j
4k
4l
nButyl
nButyl
nButyl
a
Yields based on the weight of crude product and are relative to the initial
loading of the resin.
b
The products were run on a Vydac column, gradients 5–95% formic acid in ACN
in 7 min. The purity was estimated on analytical traces at k = 214 and 254 nm.
References and notes
1. (a) Ziegert, R. E.; Toräng, J.; Knepper, K.; Bräse, S. J. Comb. Chem. 2005, 7, 147–
169; (b) Kundu, B. Curr. Opin. Drug Discovery Dev. 2003, 6, 815–826; (c) Feliu, L.;
Vera-Luque, P.; Albericio, F.; Alvarez, M. J. Comb. Chem. 2007, 9, 521–565; (d)
Gil, C.; Bräse, S. J. Comb. Chem. 2009, 11, 175–197.
2. Multicomponent Reactions; Zhu, J., Bienayme, H., Eds.; Wiley-VCH: Weinheim,
2005. and references therein.
10. The column used was
a Phenomenex (Luna 5u C18(2) 100 Å AX,
150 Â 21.20 mm 5 micron). A 5–95% gradient of water (0.1% Formic acid)
and ACN (0.1% Formic) was used at 15 ml/min for 30 min, fractions were
monitored using a Shimadzu LC–MS 2010 ESI positive mode.